You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CVKD Sale Disclosure
Pham Quang X · SEC Form 4 · Filed Jun 15, 2026
Sale
Calculated transaction value
$13.12K
Pham Quang X Chairman, CEO And Interim CFO
CVKD
Transaction date
Jun 15, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed same day
CVKD daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,666 shares @ $3.58
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001213900-26-068981
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$70.35K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. CVKD Current | Sale | Jun 15, 2026 | $13.12K |
| Cadrenal Therapeutics, Inc. CVKD | Sale | Jun 12, 2026 | $51.2K |
| Cadrenal Therapeutics, Inc. CVKD | Sale | Jun 11, 2026 | $6.02K |